Drugs repurposed as antiferroptosis agents suppress organ damage, including AKI, by functioning as lipid peroxyl radical scavengers
Journal of the American Society of Nephrology Dec 05, 2019
Mishima E, Sato E, Ito J, et al. - Using a cell-based assay, cytochrome P450 substrate compounds were screened in order to recognize drugs with antiferroptotic activity, examine the underlying mechanism and to recognize ferroptosis-causing radicals. Different US Food and Drug Administration–approved drugs and hormones that have antiferroptotic properties, like rifampicin, promethazine, omeprazole, indole-3-carbinol, carvedilol, propranolol, estradiol, and thyroid hormones were identified. However elevated lipid peroxyl radical levels could provoke ferroptosis onset, some drugs that scavenge lipid peroxyl radicals could aid in controlling ferroptosis-related disorders, such as AKI.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries